Aprameya Engineering Approves Audited Standalone and Consolidated Results for Fiscal Year 2026
Aprameya Engineering Limited announced that its Board of Directors held a meeting on May 28, 2026, approving the audited financial results for the half year and year ended March 31, 2026. The meeting approvals covered the audited financial results (both standalone and consolidated) as per Indian Accounting Standards (INDAS), the auditors' report, and the related party transaction statements. The Board also approved the appointment of Alkesh Jalan as the Scrutiniser for the Annual General Meeting for the year ended March 31, 2026.The statutory auditors, CNK & Associates LLP Chartered Accountants, issued an audit report providing an Unmodified Opinion on both the Standalone and Consolidated Financial Results for the period.
Financial Performance Highlights (Rs. In Lakhs)
The company’s results for the half year ended March 31, 2026, detail the financial performance across both standalone and consolidated entities.The following table summarizes the key financial results for the half year and the full financial year:
| Particulars | Half year ended 31.03.2026 (Audited) | Half Year ended 30.09.2025 (Unaudited) | Year ended 31.03.2026 (Audited) |
|---|---|---|---|
| Total Income | 1,289.99 | 4,233.43 | 5,523.42 |
| Total Expenses | 1,486.37 | 3,319.99 | 4,806.35 |
| Profit/(Loss) before tax | (196.38) | 913.44 | 717.07 |
| Profit/(Loss) After Tax | (171.98) | 676.08 | 504.11 |
| Total Comprehensive Income/(Loss) | (167.25) | 674.95 | 507.70 |
Consolidated Financial Results Summary
The consolidated financial statements reflect the results of the Group, which includes the subsidiary Aprameya Medtech Private Limited.The Consolidated Profit/(Loss) After Tax for the half year ended March 31, 2026, stood at (163.27) Lakhs. Meanwhile, the Consolidated Profit/(Loss) After Tax for the full year ended March 31, 2026, was 512.81 Lakhs.
The total comprehensive income attributable to owners of the company for the half year ended March 31, 2026, was (158.54) Lakhs.
Balance Sheet Snapshot
The assets and liabilities summary shows a notable difference in the total asset base between the two years.| Particulars | As at 31.03.2026 (Audited) | As at 31.03.2025 (Audited) |
|---|---|---|
| TOTAL ASSETS | 8,226.82 | 14,396.10 |
| Note: Total assets are comprising of a Non-Current Asset base of 897.17 Lakhs and a Current Asset base of 7,329.65 Lakhs. | ||
| TOTAL EQUITY AND LIABILITIES | 8,226.82 | 14,396.10 |
| The total equity attributable to equity holders of the Company stood at 6,939.91 Lakhs as of March 31, 2026. |
Cash Flow Summary (Rs. In Lakhs)
Cash flow analysis indicates the movement in cash and cash equivalents.| Particulars | Year ended 31.03.2026 | Year ended 31.03.2025 |
|---|---|---|
| Net cash from Operating Activities | 3,123.32 | (1,063.54) |
| Net cash used in Investing Activities | (445.22) | (40.63) |
| Net cash used in Financing Activities | (2,665.64) | 1,088.51 |
| Net increase in cash and cash equivalents | 12.46 | (15.65) |
Operational and Accounting Notes
The financial results include important operational details, including segmentation and subsidiary investments:- Subsidiary Investment: During the half year, the company incorporated a subsidiary, M/s Aprameya Medtech Private Limited, on October 4, 2025. The company invested in the subsidiary by subscribing to 3,50,000 Equity Shares of Rs. 10 each, aggregating to Rs. 35.00 Lakhs. Consequently, the Group holds 70% of the shareholding in this subsidiary, and the consolidated financial statements are being prepared for the first time for the half year ended March 31, 2026.
- Business Segments: The operations are structured into two major segments: Trading Sales (Medical Equipment's) and Turnkey Project Supplies (Supplies for Infra Projects for health care sectors).
- Labor Code Impact: The financial results for the half year ended March 31, 2026, incorporate the impact of gratuity liability arising from the implementation of the New Labour Codes, which was recognized as an additional expense of Rs. 11.38 Lakhs.
APRAMEYA Stock Price Movement
On Wednesday, Aprameya Engineering Limited shares slipped by 7.66% to settle at ₹173, marking a significant decline from the previous close. The stock traded on heavy volume, with 68,000 shares transacted during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.